Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)
Jan-2014A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant acinetobacter baumannii bacteremiaNg, T.M.; Teng, C.B. ; Lye, D.C.; Apisarnthanarak, A.
Jun-2012Continuation of high-dose vancomycin despite nephrotoxicityTeng, C.B. ; Rezai, K.; Itokazu, G.S.; Xamplas, R.C.; Glowacki, R.C.; Rodvold, K.A.; Weinstein, R.A.; Schwartz, D.N.
Jan-2012Guidelines for antimicrobial stewardship training and practiceTeng, C.B. ; Lee, W.; Yeo, C.L.; Lee, S.Y.; Ng, T.M.; Yeoh, S.F.; Lim, W.H.; Kwa, A.L.; Thoon, K.C.; Ooi, S.T.; Tan, T.Y.; Hsu, L.Y.; Lye, D.C.; Chlebicki, M.P.
Oct-2011Nonconcordance with surgical site infection prevention guidelines and rates of surgical site infections for general surgical, neurological, and orthopedic proceduresYoung, B.; Ng, T.M.; Teng, C. ; Ang, B.; Tai, H.Y.; Lye, D.C.
2014Optimization of Vancomycin Dosing in Very Low-Birth-Weight Preterm NeonatesMadigan, T.; Teng, C.B. ; Koshaish, J.; Johnson, K.R.; Graner, K.K.; Banerjee, R.
Mar-2012Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: Correlation with outcomesGrim, S.A.; Berger, K.; Teng, C. ; Gupta, S.; Layden, J.E.; Janda, W.M.; Clark, N.M.
2013Vancomycin monotherapy vs. combination therapy for the treatment of persistent methicillinresistant staphylococcus aureus bacteremiaSeah, J.; Lye, D.C.; Ng, T.-M.; Krishnan, P.; Choudhury, S.; Teng, C.B.